XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenues $ 204,495 $ 151,976 $ 107,518
Cost of revenues (195,422) (194,719) (90,378)
Gross profit 9,073 (42,743) 17,140
Operating expenses:      
General and administrative expenses (104,572) (101,632) (18,849)
Research and development expenses (43,508) (34,385) (16,637)
Selling and marketing expenses (22,611) (21,431) (13,761)
Total operating expenses (170,691) (157,448) (49,247)
Subsidy income 1,672 6,127 3,000
Loss from operations (159,946) (194,064) (29,107)
Other income and expenses:      
Interest income 3,179 446 571
Interest expense (3,323) (5,411) (5,738)
Loss on changes in fair value of Bridge Notes 0 (9,861) 0
Gain on changes in fair value of warrant liability 979 2,469 0
Other income (expense), net 944 (62) 650
Loss before provision for income tax (158,167) (206,483) (33,624)
Income tax expense (33) 0 (1)
Net loss (158,200) (206,483) (33,625)
Less: Accretion of Series C1 Preferred 0 2,257 3,897
Less: Accretion of Series C2 Preferred 0 5,132 8,866
Less: Accretion of Series D1 Preferred 0 10,708 18,648
Less: Accretion for noncontrolling interests 0 9,523 15,927
Net loss attributable to common stock shareholders of Microvast Holdings, Inc. $ (158,200) $ (234,103) $ (80,963)
Net loss per share attributable to Common Stock shareholders of Microvast Holdings, Inc.      
Basic (in dollars per share) $ (0.52) $ (1.26) $ (0.82)
Diluted (in dollars per share) $ (0.52) $ (1.26) $ (0.82)
Weighted average shares used in calculating net loss per share of common stock:      
Weighted average shares used in calculating net loss per share of common stock, basic (in shares) 303,279,188 185,896,482 99,028,297
Weighted average shares used in calculating net loss per share of common stock, diluted (in shares) 303,279,188 185,896,482 99,028,297